Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage regime with esketamine for treating major depressive disorder

Dosage regime with esketamine for treating major depressive disorder

US Patent 12076300 · Granted Sep 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regime with esketamine for treating major depressive disorder2025
Dosage regime with esketamine for treating major depressive disorder2025
Methods of determining response to therapy2017